Cargando…

Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China

Daniel Kramer and colleagues compare strategies for postmarket surveillance of medical devices and discuss ways to improve these systems. Please see later in the article for the Editors' Summary

Detalles Bibliográficos
Autores principales:	Kramer, Daniel B., Tan, Yongtian T., Sato, Chiaki, Kesselheim, Aaron S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Policy Forum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3815401/ https://www.ncbi.nlm.nih.gov/pubmed/24223035 http://dx.doi.org/10.1371/journal.pmed.1001519

Ejemplares similares

Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures
por: Brown, Beatrice L., et al.
Publicado: (2023)

EU postmarket surveillance plans for medical devices
por: Pane, Josep, et al.
Publicado: (2019)

An Uninformative Truth: The Logic of Amarin’s Off-Label Promotion
por: Hey, Spencer Phillips, et al.
Publicado: (2016)

Biomarker-Defined Subsets of Common Diseases: Policy and Economic Implications of Orphan Drug Act Coverage
por: Kesselheim, Aaron S., et al.
Publicado: (2017)

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
por: Sarpatwari, Ameet, et al.
Publicado: (2015)

EU-US Relations: Reinventing the Transatlantic Agenda
por: Blockmans, Steven
Publicado: (2021)

Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
por: Hines, Jonas Zajac, et al.
Publicado: (2010)

Syndromic Surveillance: Adapting Innovations to Developing Settings
por: Chretien, Jean-Paul, et al.
Publicado: (2008)

Big Data Opportunities for Global Infectious Disease Surveillance
por: Hay, Simon I., et al.
Publicado: (2013)

Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination
por: Sturrock, Hugh J. W., et al.
Publicado: (2013)

Application of orphan drug designation to cancer treatments (2008–2017): a comprehensive and comparative analysis of the USA and EU
por: Vokinger, Kerstin Noëlle, et al.
Publicado: (2019)

Policy Coherence in US Tobacco Control: Beyond FDA Regulation
por: Yang, Joshua S., et al.
Publicado: (2009)

Documenting Mortality in Crises: What Keeps Us from Doing Better
por: Checchi, Francesco, et al.
Publicado: (2008)

Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action
por: Wi, Teodora, et al.
Publicado: (2017)

The US Anti-Prostitution Pledge: First Amendment Challenges and Public Health Priorities
por: Masenior, Nicole Franck, et al.
Publicado: (2007)

Compromise or Capitulation? US Food and Drug Administration Jurisdiction Over Tobacco Products
por: Glantz, Stanton A., et al.
Publicado: (2009)

Conducting Unlinked Anonymous HIV Surveillance in Developing Countries: Ethical, Epidemiological, and Public Health Concerns
por: Rennie, Stuart, et al.
Publicado: (2009)

The US Food and Drug Administration Provides a Pathway for Licensing Vaccines for Global Diseases
por: Brennan, Michael J.
Publicado: (2009)

Government Inaction on Ratings and Government Subsidies to the US Film Industry Help Promote Youth Smoking
por: Millett, Christopher, et al.
Publicado: (2011)

The Role of Public Health Institutions in Global Health System Strengthening Efforts: The US CDC's Perspective
por: Bloland, Peter, et al.
Publicado: (2012)

Surveillance of antimicrobial consumption in animal production sectors of low- and middle-income countries: Optimizing use and addressing antimicrobial resistance
por: Schar, Daniel, et al.
Publicado: (2018)

New era of drug innovation in China
por: Ye, Xuan, et al.
Publicado: (2019)

A Public Health Framework for Legalized Retail Marijuana Based on the US Experience: Avoiding a New Tobacco Industry
por: Barry, Rachel Ann, et al.
Publicado: (2016)

The EU Industrial Strategy: Towards a Post-Growth Agenda?
por: Renda, Andrea
Publicado: (2021)

China's Engagement with Global Health Diplomacy: Was SARS a Watershed?
por: Chan, Lai-Ha, et al.
Publicado: (2010)

Combining Domestic and Foreign Investment to Expand Tuberculosis Control in China
por: Jia, Zhong-wei, et al.
Publicado: (2010)

Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022)

Angina, “Normal” Coronary Angiography, and Vascular Dysfunction: Risk Assessment Strategies
por: Bugiardini, Raffaele, et al.
Publicado: (2007)

Fiscal Stimulus: Lessons From the US to the EU?
Publicado: (2021)

Community-based strategies to strengthen men’s engagement in the HIV care cascade in sub-Saharan Africa
por: Sharma, Monisha, et al.
Publicado: (2017)

Pediatric Oncology as the Next Global Child Health Priority: The Need for National Childhood Cancer Strategies in Low- and Middle-Income Countries
por: Gupta, Sumit, et al.
Publicado: (2014)

Assessing process, content, and politics in developing the global health sector strategy on sexually transmitted infections 2016–2021: Implementation opportunities for policymakers
por: Seale, Andy, et al.
Publicado: (2017)

Assessment of the Benefits of Targeted Interventions for Pandemic Control in China Based on Machine Learning Method and Web Service for COVID-19 Policy Simulation
por: WU, Jie Wen, et al.
Publicado: (2022)

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020
por: Moneer, Osman, et al.
Publicado: (2021)

Getting It Right: Being Smarter about Clinical Trials
por: Kramer, Barnett S, et al.
Publicado: (2006)

Educating a New Generation of Doctors to Improve the Health of Populations in Low- and Middle-Income Countries
por: Celletti, Francesca, et al.
Publicado: (2011)

Responding to AIDS, Tuberculosis, Malaria, and Emerging Infectious Diseases in Burma: Dilemmas of Policy and Practice
por: Beyrer, Chris, et al.
Publicado: (2006)

Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance
por: Kramer, Daniel B., et al.
Publicado: (2012)

Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017
por: Zhu, Xingyue, et al.
Publicado: (2022)

Slowbalisation in the Context of US-China Decoupling
por: Garcia-Herrero, Alicia
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l3rvp1uanlf7i0sf6kf4bokudp